Latest Insider Transactions at Lhc Group, Inc (LHCG)
This section provides a real-time view of insider transactions for Lhc Group, Inc (LHCG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LHC Group, Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LHC Group, Inc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 22
2023
|
W Earl Reed Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
57,848
-100.0%
|
$9,834,160
$170.0 P/Share
|
Feb 22
2023
|
W Earl Reed Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
80,949
-100.0%
|
$13,761,330
$170.0 P/Share
|
Feb 22
2023
|
Jonathan Goldberg Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,894
-100.0%
|
$1,171,980
$170.0 P/Share
|
Feb 22
2023
|
Jonathan Goldberg Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,578
-100.0%
|
$8,598,260
$170.0 P/Share
|
Feb 22
2023
|
Dale Mackel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,039
-100.0%
|
$3,066,630
$170.0 P/Share
|
Feb 22
2023
|
Bruce D Greenstein Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,806
-87.2%
|
$3,468,510
$85.0 P/Share
|
Feb 22
2023
|
Teri G. Fontenot Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-100.0%
|
$1,309,000
$170.0 P/Share
|
Feb 22
2023
|
Brent Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,200
-100.0%
|
$2,414,000
$170.0 P/Share
|
Feb 22
2023
|
Ronald T Nixon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,100
-100.0%
|
$4,607,000
$170.0 P/Share
|
Feb 22
2023
|
Monica F Azare Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,500
-100.0%
|
$5,185,000
$170.0 P/Share
|
Feb 22
2023
|
Clifford S Holtz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,023
-100.0%
|
$2,043,910
$170.0 P/Share
|
Feb 22
2023
|
Kimberly S Seymour |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,595
-86.11%
|
$475,575
$85.0 P/Share
|
Feb 22
2023
|
Keith G Myers CEO and Chairman |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
604,013
-100.0%
|
$102,682,210
$170.0 P/Share
|
Feb 22
2023
|
Keith G Myers CEO and Chairman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
299,545
-66.49%
|
$25,461,325
$85.0 P/Share
|
Feb 22
2023
|
Joshua L. Proffitt President and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
117,443
-80.44%
|
$9,982,655
$85.0 P/Share
|
Feb 22
2023
|
Nicholas Gachassin Iii EVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,860
-100.0%
|
$2,696,200
$170.0 P/Share
|
Feb 22
2023
|
John L Indest Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
30,576
-100.0%
|
$5,197,920
$170.0 P/Share
|
Feb 22
2023
|
John L Indest Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,372
-100.0%
|
$743,240
$170.0 P/Share
|
Feb 13
2023
|
W Earl Reed Iii Director |
BUY
Grant, award, or other acquisition
|
Indirect |
30,000
+50.0%
|
-
|
Feb 13
2023
|
W Earl Reed Iii Director |
SELL
Bona fide gift
|
Direct |
30,000
-27.04%
|
-
|
Jan 31
2023
|
Joshua L. Proffitt President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,205
+8.71%
|
-
|
Jan 31
2023
|
Keith G Myers CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
15,125
+4.03%
|
-
|
Jan 31
2023
|
Nicholas Gachassin Iii EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,820
+15.1%
|
-
|
Jan 31
2023
|
Bruce D Greenstein Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,680
+14.07%
|
-
|
Jan 31
2023
|
Kimberly S Seymour |
BUY
Grant, award, or other acquisition
|
Direct |
1,075
+16.12%
|
-
|
Aug 01
2022
|
Joshua L. Proffitt President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,185
-1.1%
|
$191,970
$162.58 P/Share
|
Aug 01
2022
|
Bruce D Greenstein Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-0.99%
|
$55,080
$162.58 P/Share
|
Jul 01
2022
|
Bruce D Greenstein Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-0.28%
|
$14,880
$155.05 P/Share
|
May 01
2022
|
Joshua L. Proffitt President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
992
-0.92%
|
$163,680
$165.85 P/Share
|
Apr 07
2022
|
Keith G Myers CEO and Chairman |
SELL
Bona fide gift
|
Direct |
120
-0.03%
|
-
|
Mar 30
2022
|
Keith G Myers CEO and Chairman |
SELL
Bona fide gift
|
Direct |
500
-0.14%
|
-
|
Mar 01
2022
|
Dale Mackel |
BUY
Grant, award, or other acquisition
|
Direct |
16,295
+47.46%
|
-
|
Mar 01
2022
|
Kimberly S Seymour |
BUY
Grant, award, or other acquisition
|
Direct |
1,530
+25.29%
|
-
|
Mar 01
2022
|
Kimberly S Seymour |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-7.69%
|
$34,611
$139.78 P/Share
|
Mar 01
2022
|
Clifford S Holtz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+8.38%
|
-
|
Mar 01
2022
|
Ronald T Nixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+3.9%
|
-
|
Mar 01
2022
|
W Earl Reed Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+0.98%
|
-
|
Mar 01
2022
|
Joshua L. Proffitt President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
25,830
+19.24%
|
-
|
Mar 01
2022
|
Teri G. Fontenot Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+12.5%
|
-
|
Mar 01
2022
|
Brent Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+7.19%
|
-
|
Mar 01
2022
|
Keith G Myers CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
31,845
+8.44%
|
-
|
Mar 01
2022
|
Jonathan Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+2.13%
|
-
|
Mar 01
2022
|
Monica F Azare Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+3.48%
|
-
|
Mar 01
2022
|
John L Indest Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+20.1%
|
-
|
Mar 01
2022
|
Nicholas Gachassin Iii EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,180
+24.27%
|
-
|
Mar 01
2022
|
Bruce D Greenstein Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,185
+21.0%
|
-
|
Jan 03
2022
|
Nicholas Gachassin Iii EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-3.32%
|
$34,113
$137.23 P/Share
|
Dec 16
2021
|
Nicholas Gachassin Iii EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
800
-9.63%
|
$100,000
$125.25 P/Share
|
Nov 01
2021
|
Dale Mackel |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-3.91%
|
$9,869
$139.91 P/Share
|
Sep 09
2021
|
Keith G Myers CEO and Chairman |
SELL
Bona fide gift
|
Direct |
5,000
-1.57%
|
-
|